ICP-488

Tel Aviv, Israel & Raleigh, N.C., July 28, 2026 RedHill Biopharma Ltd. has announced significant progress in the emergency...

Amsterdam, Netherlands, July 27, 2026 Royal Philips has reported solid second-quarter 2026 financial results, driven by 4% comparable sales...

Beijing, July 27, 2026 InnoCare Pharma has announced that its novel TYK2 (Tyrosine Kinase 2) inhibitor fadeucravacitinib (ICP-488) successfully...